Clene, Inc. (CLNN)
4.23
-0.24
(-5.37%)
USD |
NASDAQ |
Aug 28, 16:00
4.24
+0.01
(+0.24%)
After-Hours: 20:00
Clene Free Cash Flow : -16.00M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.00M |
| March 31, 2026 | -18.15M |
| December 31, 2025 | -18.63M |
| September 30, 2025 | -18.64M |
| June 30, 2025 | -17.70M |
| March 31, 2025 | -19.34M |
| December 31, 2024 | -21.42M |
| September 30, 2024 | -23.76M |
| June 30, 2024 | -27.53M |
| March 31, 2024 | -28.16M |
| December 31, 2023 | -30.56M |
| September 30, 2023 | -32.85M |
| June 30, 2023 | -36.14M |
| March 31, 2023 | -39.72M |
| December 31, 2022 | -44.24M |
| September 30, 2022 | -44.93M |
| Date | Value |
|---|---|
| June 30, 2022 | -42.33M |
| March 31, 2022 | -40.53M |
| December 31, 2021 | -35.88M |
| September 30, 2021 | -43.77M |
| June 30, 2021 | -44.07M |
| March 31, 2021 | -37.64M |
| December 31, 2020 | -31.55M |
| September 30, 2020 | -13.54M |
| June 30, 2020 | -5.931M |
| March 31, 2020 | -3.776M |
| December 31, 2019 | -0.5977M |
| September 30, 2019 | -0.4803M |
| June 30, 2019 | -0.4237M |
| March 31, 2019 | -0.2883M |
| December 31, 2018 | -0.2056M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| NovelStem International Corp. | -0.2295M |
| Brainstorm Cell Therapeutics, Inc. | -4.057M |
| Summit Therapeutics, Inc. | -458.40M |
| Kezar Life Sciences, Inc. | -42.03M |
| Protara Therapeutics, Inc. | -66.49M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.578M |
| Cash from Investing (Quarterly) | -0.001M |
| Cash from Financing (Quarterly) | 6.313M |
| Free Cash Flow Per Share (Quarterly) | -0.2083 |
| Free Cash Flow to Equity (Quarterly) | -2.875M |
| Free Cash Flow to Firm (Quarterly) | -1.884M |
| Free Cash Flow Yield | -33.77% |